Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of CryoPort Inc (NASDAQ: CYRX) closed at $6.04 in the last session, down -2.89% from day before closing price of $6.22. In other words, the price has decreased by -$2.89 from its previous closing price. On the day, 0.25 million shares were traded. CYRX stock price reached its highest trading level at $6.085 during the session, while it also had its lowest trading level at $5.9052.
Ratios:
We take a closer look at CYRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.24 and its Current Ratio is at 5.56. In the meantime, Its Debt-to-Equity ratio is 0.61 whereas as Long-Term Debt/Eq ratio is at 0.56.
On December 19, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $11.
Jefferies Downgraded its Buy to Hold on August 07, 2024, whereas the target price for the stock was revised from $20 to $8.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 24 ’25 when Sawicki Mark W sold 1,349 shares for $6.94 per share. The transaction valued at 9,364 led to the insider holds 84,087 shares of the business.
STEFANOVICH ROBERT sold 1,070 shares of CYRX for $7,428 on Mar 24 ’25. The Chief Financial Officer now owns 190,349 shares after completing the transaction at $6.94 per share. On Mar 24 ’25, another insider, SHELTON JERRELL, who serves as the President, CEO of the company, sold 2,980 shares for $6.94 each. As a result, the insider received 20,686 and left with 762,419 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYRX now has a Market Capitalization of 302828672 and an Enterprise Value of 337740800. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.41 while its Price-to-Book (P/B) ratio in mrq is 0.84. Its current Enterprise Value per Revenue stands at 1.455 whereas that against EBITDA is -10.349.
Stock Price History:
The Beta on a monthly basis for CYRX is 1.87, which has changed by -0.45683455 over the last 52 weeks, in comparison to a change of 0.09362543 over the same period for the S&P500. Over the past 52 weeks, CYRX has reached a high of $11.64, while it has fallen to a 52-week low of $4.58. The 50-Day Moving Average of the stock is 0.70%, while the 200-Day Moving Average is calculated to be -15.99%.
Shares Statistics:
According to the various share statistics, CYRX traded on average about 545.66K shares per day over the past 3-months and 478300 shares per day over the past 10 days. A total of 50.14M shares are outstanding, with a floating share count of 48.29M. Insiders hold about 3.69% of the company’s shares, while institutions hold 93.04% stake in the company. Shares short for CYRX as of 1745971200 were 2648061 with a Short Ratio of 4.85, compared to 1743379200 on 2443367. Therefore, it implies a Short% of Shares Outstanding of 2648061 and a Short% of Float of 6.34.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
